This biomarker for T1D risk is detectable very early in life, but is difficult to quantify above the inherent background of prostanoid activation due to blood collection and processing, (e.g., activation of PTGS2 mRNA in monocytes by adherence to glass or endotoxin contamination within 90 min ex vivo). This evidence concerns the gene PTGS2 and type 1 diabetes mellitus.